Understanding SARS-CoV-2-Mediated Inflammatory Responses: From
Por um escritor misterioso
Descrição
Currently there is no effective antiviral therapy for SARS-CoV-2 infection, which frequently leads to fatal inflammatory responses and acute lung injury. Here, we discuss the various mechanisms of SARS-CoV-mediated inflammation. We also assume that SARS-CoV-2 likely shares similar inflammatory responses. Potential therapeutic tools to reduce SARS-CoV-2-induced inflammatory responses include various methods to block FcR activation. In the absence of a proven clinical FcR blocker, the use of intravenous immunoglobulin to block FcR activation may be a viable option for the urgent treatment of pulmonary inflammation to prevent severe lung injury. Such treatment may also be combined with systemic anti-inflammatory drugs or corticosteroids. However, these strategies, as proposed here, remain to be clinically tested for effectiveness.
Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
COVID-19 Vaccines in Patients with Immune-Mediated Inflammatory Diseases – Consult QD
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis: Trends in Immunology
COVID-19 infection: an overview on cytokine storm and related interventions, Virology Journal
SARS-CoV-2 pathogenesis Nature Reviews Microbiology
Physical activity and anti-inflammatory response in SARS-CoV2
Frontiers Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19
Full article: JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Cell‐mediated immunity to SARS‐CoV‐2 - Wang - 2020 - Pediatric Investigation - Wiley Online Library
Covid-19 Effects on organs
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions - Jiang - 2022 - MedComm - Wiley Online Library
de
por adulto (o preço varia de acordo com o tamanho do grupo)
